Dashboard
Manage Tickers

OMER OMEROS CORP

Nasdaq omeros.com


$ 7.82 $ -0.38 (-4.61 %)    

Tuesday, 21-Oct-2025 19:24:09 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 610.29 $ -0.16 (-0.03 %)
DIA $ 469.10 $ 2.20 (0.47 %)
SPY $ 670.98 $ -0.01 (0 %)
TLT $ 91.99 $ 0.45 (0.49 %)
GLD $ 376.61 $ -25.91 (-6.43 %)
$ 7.87
$ 8.15
$ 7.78 x 5
$ 7.96 x 64
$ 7.77 - $ 8.32
$ 2.95 - $ 13.60
2,363,737
na
535.6M
$ 1.75
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-14-2025 06-30-2025 10-Q
2 05-15-2025 03-31-2025 10-Q
3 03-31-2025 12-31-2024 10-K
4 11-13-2024 09-30-2024 10-Q
5 08-07-2024 06-30-2024 10-Q
6 05-15-2024 03-31-2024 10-Q
7 04-01-2024 12-31-2023 10-K
8 11-09-2023 09-30-2023 10-Q
9 08-09-2023 06-30-2023 10-Q
10 05-09-2023 03-31-2023 10-Q
11 03-13-2023 12-31-2022 10-K
12 11-09-2022 09-30-2022 10-Q
13 08-09-2022 06-30-2022 10-Q
14 05-10-2022 03-31-2022 10-Q
15 03-01-2022 12-31-2021 10-K
16 11-09-2021 09-30-2021 10-Q
17 08-09-2021 06-30-2021 10-Q
18 05-10-2021 03-31-2021 10-Q
19 03-01-2021 12-31-2020 10-K
20 11-09-2020 09-30-2020 10-Q
21 08-10-2020 06-30-2020 10-Q
22 05-11-2020 03-31-2020 10-Q
23 03-02-2020 12-31-2019 10-K
24 11-12-2019 09-30-2019 10-Q
25 08-08-2019 06-30-2019 10-Q
26 05-09-2019 03-31-2019 10-Q
27 03-01-2019 12-31-2018 10-K
28 11-08-2018 09-30-2018 10-Q
29 08-09-2018 06-30-2018 10-Q
30 05-10-2018 03-31-2018 10-Q
31 03-01-2018 12-31-2017 10-K
32 11-09-2017 09-30-2017 10-Q
33 08-08-2017 06-30-2017 10-Q
34 05-10-2017 03-31-2017 10-Q
35 03-16-2017 12-31-2016 10-K
36 11-09-2016 09-30-2016 10-Q
37 08-09-2016 06-30-2016 10-Q
38 05-10-2016 03-31-2016 10-Q
39 03-15-2016 12-31-2015 10-K
40 11-09-2015 09-30-2015 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

4-biotech-stocks-lifting-off-as-momentum-builds
4 Biotech Stocks Lifting Off As Momentum B...
10/21/2025 15:49:39

Biotech stocks have trailed the broader market this year, but more names are starting to show strength as the rally expands and...

gold-falls-1-slb-posts-better-than-expected-q3-earnings
Gold Falls 1%; SLB Posts Better-Than-Expec...
10/17/2025 16:17:56

d-boral-capital-maintains-buy-on-omeros-maintains-36-price-target
D. Boral Capital Maintains Buy on Omeros, ...
10/16/2025 19:22:01

D. Boral Capital analyst Jason Kolbert maintains Omeros (NASDAQ:OMER) with a Buy and maintains $36 price target.

omeros-published-study-in-blood-advances-shows-narsoplimab-significantly-improves-survival-in-high-risk-ta-tma-patients
Omeros Published Study In "Blood Advances"...
10/16/2025 12:39:07

Omeros Corporation (NASDAQ:OMER) today announced the publication of a peer-reviewed manuscript in Blood Advances, a journal of ...

satellogic-hewlett-packard-enterprise-bitfarms-and-other-big-stocks-moving-lower-in-thursdays-pre-market-session
Satellogic, Hewlett Packard Enterprise, Bi...
10/16/2025 12:01:21

why-jb-hunt-transport-shares-are-trading-higher-by-13-here-are-20-stocks-moving-premarket
Why J.B. Hunt Transport Shares Are Trading...
10/16/2025 09:30:41

hims--hers-salesforce-omeros-united-airlines-and-sea-ltd-why-these-5-stocks-are-on-investors-radars-today
Hims & Hers, Salesforce, Omeros, United Ai...
10/16/2025 01:36:24

Major U.S. indices ended mixed on Wednesday, with the Dow Jones Industrial Average slipping 0.04% to 46,253.31.

omeros-stock-skyrockets-after-novo-nordisk-strikes-21b-rare-disease-drug-deal
Omeros Stock Skyrockets After Novo Nordisk...
10/15/2025 18:58:04

Omeros stock jumps 164% as Novo Nordisk acquires global rights to zaltenibart, with potential milestones reaching $2.1 billion ...

gold-gains-over-1-abbott-shares-fall-after-q3-results
Gold Gains Over 1%; Abbott Shares Fall Aft...
10/15/2025 18:20:16

needham-reiterates-hold-on-omerosto-hold
Needham Reiterates Hold on Omerosto Hold
10/15/2025 17:47:38

Needham analyst Serge Belanger reiterates Omeros (NASDAQ:OMER) from Hold to Hold.

Core News & Articles
12 Health Care Stocks Moving In Wednesday'...
10/15/2025 17:07:00

wbb-securities-reiterates-strong-buy-on-omeros-maintains-45-price-target
WBB Securities Reiterates Strong Buy on Om...
10/15/2025 16:11:14

WBB Securities analyst Steve Brozak reiterates Omeros (NASDAQ:OMER) with a Strong Buy and maintains $45 price target.

hc-wainwright--co-maintains-buy-on-omeros-raises-price-target-to-20
HC Wainwright & Co. Maintains Buy on Omero...
10/15/2025 16:05:25

HC Wainwright & Co. analyst Brandon Folkes maintains Omeros (NASDAQ:OMER) with a Buy and raises the price target from $9...

sp-500-gains-1-bank-of-america-posts-upbeat-earnings
S&P 500 Gains 1%; Bank of America Posts Up...
10/15/2025 14:17:51

d-boral-capital-maintains-buy-on-omeros-maintains-36-price-target
D. Boral Capital Maintains Buy on Omeros, ...
10/15/2025 13:40:01

D. Boral Capital analyst Jason Kolbert maintains Omeros (NASDAQ:OMER) with a Buy and maintains $36 price target.

Core News & Articles
Novo Nordisk Acquires Global Rights To Zal...
10/15/2025 12:34:16

Zaltenibart has best-in-class potential across multiple rare blood and kidney disorders and will enhance Novo Nordisk's Rar...

d-boral-capital-maintains-buy-on-omeros-maintains-36-price-target
D. Boral Capital Maintains Buy on Omeros, ...
09/03/2025 11:15:15

D. Boral Capital analyst Jason Kolbert maintains Omeros (NASDAQ:OMER) with a Buy and maintains $36 price target.

omeros-corp-reports-survival-outcomes-with-narsoplimab-in-ta-tma-patients-in-peer-reviewed-study-published-in-american-journal-of-hematology
Omeros Corp. Reports Survival Outcomes Wit...
09/02/2025 12:48:40

Omeros Corporation (NASDAQ:OMER) today announced the publication of a peer-reviewed manuscript in the American Journal of Hemat...

d-boral-capital-maintains-buy-on-omeros-maintains-36-price-target
D. Boral Capital Maintains Buy on Omeros, ...
08/15/2025 11:11:47

D. Boral Capital analyst Jason Kolbert maintains Omeros (NASDAQ:OMER) with a Buy and maintains $36 price target.

needham-reiterates-hold-on-omerosto-hold
Needham Reiterates Hold on Omerosto Hold
08/15/2025 10:02:16

Needham analyst Serge Belanger reiterates Omeros (NASDAQ:OMER) from Hold to Hold.

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION